Paper
0
OS-079-YI Development and validation of the CABLE score to estimate individual prognosis of patients with hepatocellular carcinoma treated with 1L atezolizumab and bevacizumab
Authors
Simon Gairing,P Mildenberger
Jennifer Gile,Fabian Artusa,Bernhard Scheiner,Catherine Leyh,Sabine Lieb,Friedrich Sinner,Vincent Jörg,Thorben Fruendt,Vera Himmelsbach,Nada Abedin,Cennet Şahin,K. Boettcher,Jasmin Schuhbaur,Simon Labuhn,James Korolewicz,Claudia Fulgenzi,Antonio D’Alessio,Valentina Zanuso,Florian Hucke,Natascha Röhlen,Najib Khaled,Eleonora Ramadori,Lukáš Müller,Arndt Weinmann,Roman Kloeckner,Peter Galle,Nguyen Tran,Sudhakar Venkatesh,Andreas Teufel,Enrico Toni,D. Waldschmidt,Jens Marquardt,Dominik Bettinger,Markus Peck‐Radosavljevic,Andreas Geier,Florian Reiter,Lorenza Rimassa,David Pinato,Christoph Roderburg,Thomas Ettrich,Michael Bitzer,Veit Scheble,Ursula Ehmer,Marie‐Luise Berres,Fabian Finkelmeier,Maria González-Carmona,Johann Felden,Kornelius Schulze,Marino Venerito,Florian Bömmel,Leonie Jochheim,Matthias Pinter,Rephael Mohr,Sumera Ilyas,Irene Schmidtmann,Friedrich Foerster
+56 authors
,Katrin BoettcherJournal
Published
Jun 1, 2024
Show more
Save
Tip0
TipSave